Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Scottish Enterprise have appointed a supplier to deliver services to facilitate the identification of new and promising technologies in the Advanced Therapy Medicinal Products (ATMPs) and Vaccine markets within the Scottish academic community and accelerate their development towards commercialisation. The contract will start on the 22nd of September 2024 for a period of 24 months, with the option to extend the contract by a further period of 3 months (for time only). The value of the contract is 99,483GBP excluding VAT.
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Cell and Gene Therapy Catapult | 10016023 | - | 1 lot Lot 1 | - |
This procurement was divided into 1 lots, each awarded separately. 1 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 | £99,483 initial term | 1 single bid — no competition | Cell and Gene Therapy Catapult | complete |
This supplier has only 1 government contract in our database. These payments are likely for this contract.